Current role
Former Chief
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Nkarta, Inc. (NKTX)
Proxy statement
Current -
Karyopharm Therapeutics Inc. (KPTI)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Nkarta, Inc.
Current role
NKTX
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Karyopharm Therapeutics Inc. (KPTI) | Development Officer | $429,525 | $1,577,203 |
| 2020 | Karyopharm Therapeutics Inc. (KPTI) | Scientific Officer | $483,624 | $3,670,884 |
| 2019 | Nkarta, Inc. (NKTX) | Financial Officer | $342,876 | $1,056,798 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.